FDA 510(k)

Alere i Influenza A & B, Alere i Estreptococo A, Alere i RSV, Alere i Influenza A & B 2

Número K: K173932 · 2018-01-26

Data da decisão2018-01-26

Código do produtoOCC

Comité consultivoMI

DecisãoSubstantially Equivalent

Resumo do dispositivo

Alere i Influenza A & B, Alere i Strep A, Alere i RSV, Alere i Influenza A & B 2 is the device name listed in this FDA 510(k) record. The listed applicant is Alere Scarborough, Inc.. It received FDA 510(k) clearance on 2018-01-26 under 510(k) number K173932. The device is classified under product code OCC. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

Perguntas frequentes

What is the Alere i Influenza A & B, Alere i Strep A, Alere i RSV, Alere i Influenza A & B 2?

Alere i Influenza A & B, Alere i Strep A, Alere i RSV, Alere i Influenza A & B 2 is a medical device that received FDA 510(k) clearance on 2018-01-26. The listed applicant is Alere Scarborough, Inc.. The 510(k) number is K173932.

When did Alere i Influenza A & B, Alere i Strep A, Alere i RSV, Alere i Influenza A & B 2 receive FDA 510(k) clearance?

Alere i Influenza A & B, Alere i Strep A, Alere i RSV, Alere i Influenza A & B 2 received FDA 510(k) clearance on 2018-01-26, under 510(k) number K173932.

Who is the listed applicant for Alere i Influenza A & B, Alere i Strep A, Alere i RSV, Alere i Influenza A & B 2?

The FDA 510(k) record lists Alere Scarborough, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Alere i Influenza A & B, Alere i Strep A, Alere i RSV, Alere i Influenza A & B 2?

The FDA product code for Alere i Influenza A & B, Alere i Strep A, Alere i RSV, Alere i Influenza A & B 2 is OCC.

Ensaios clínicos relacionados

Registros relacionados são pareados automaticamente usando nomes, códigos de produtos ou outros metadados. Um pareamento não estabelece um vínculo clínico, científico, corporativo ou regulatório verificado; revise as fontes oficiais vinculadas.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITING NCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITING NCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDED NCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Outros registros que listam Alere Scarborough, Inc. como candidato(a)

K190204ID NOW Influenza A & B 2 K181853Alere BinaxNOW Cartão de Influenza A & B 2, Leitor Alere K173653Alere i Strep A 2, Alere i instrumento, Alere i Strep A 2 Control Swab Kit K173502Alere BinaxNOW Cartão de Influenza A & B 2, Leitor Alere, Kit de Swab de Controle do Alere BinaxNOW Influenza A & B 2 K171792Alere i Influenza A & B 2, Alere i Instrumento, Kit de Swab de Controle de Influenza A & B Alere i K162642Alere BinaxNOW Cartão de Influenza A & B 2, Leitor Alere, Kit de Swab de Controle do Alere BinaxNOW Influenza A & B 2

Ver todos os 10 dispositivos →

Dispositivos Relacionados (Código: OCC)

K262747ID NOW Influenza A & B 2; ID NOW RSV; ID NOW Strep A 2; ID NOW COVID-19 2.0Abbott Diagnostics Scarborough, Inc.K254139BioCode® Respiratory Pathogen Panel (RPP)Applied BioCode, Inc.K242613NxTAG® Respiratory Pathogen PanelLuminex Molecular Diagnostics, Inc.K232775ID NOW Influenza A & B 2Abbott Diagnostics Scarborough, Inc.K231017Panther Fusion AdV/hMPV/RV AssayHologic, Inc.K213822cobas Influenza A/B & RSV nucleic acid test for use on the cobas Liat SystemRoche Molecular Systems, Inc.

Fonte oficial

Ver na base de dados da FDA →

Dados provenientes da FDA Open API. Para informações mais recentes e oficiais, consulte sempre o registro oficial.